UK markets closed

Pulmonx Corporation (LUNG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.54+0.14 (+1.89%)
As of 12:45PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 286.43M
Enterprise value 210.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.08
Price/book (mrq)2.42
Enterprise value/revenue 3.07
Enterprise value/EBITDA -3.80

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-36.75%
S&P500 52-week change 323.06%
52-week high 314.84
52-week low 37.21
50-day moving average 39.73
200-day moving average 310.95

Share statistics

Avg vol (3-month) 3572.97k
Avg vol (10-day) 3561k
Shares outstanding 538.81M
Implied shares outstanding 638.81M
Float 836.98M
% held by insiders 14.68%
% held by institutions 192.93%
Shares short (28 Mar 2024) 41.13M
Short ratio (28 Mar 2024) 41.74
Short % of float (28 Mar 2024) 44.14%
Short % of shares outstanding (28 Mar 2024) 42.90%
Shares short (prior month 29 Feb 2024) 41.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -88.60%
Operating margin (ttm)-72.20%

Management effectiveness

Return on assets (ttm)-20.84%
Return on equity (ttm)-44.69%

Income statement

Revenue (ttm)68.67M
Revenue per share (ttm)1.81
Quarterly revenue growth (yoy)25.00%
Gross profit (ttm)N/A
EBITDA -60.39M
Net income avi to common (ttm)-60.84M
Diluted EPS (ttm)-1.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)117.1M
Total cash per share (mrq)3.04
Total debt (mrq)41.42M
Total debt/equity (mrq)35.01%
Current ratio (mrq)6.50
Book value per share (mrq)3.07

Cash flow statement

Operating cash flow (ttm)-37.61M
Levered free cash flow (ttm)-20.59M